The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells

By sjmartinez • February 19, 2024

Lewis MI, Shapiro S, Oudiz RJ, Nakamura M, Geft D, Matusov Y, Hage A, Tapson VF, Henry TD, Azizad P, Saggar R, Mirocha J, Karpov OA, Van Eyk JE, Marbán E. The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells. EBioMedicine. 2024 Feb;100:104900. doi: 10.1016/j.ebiom.2023.104900. Epub 2023 Dec 12. PMID: 38092579.

Tags: Cardiology/Epi, Cedars Sinai DoM, Harbor UCLA, Progenitor cell therapy, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine, Regenerative medicine, right ventricle, Short- and long-term safety, Veterans Administration

Differences in Ambulatory Care Outcomes Between Trainees and Faculty: A Multi-center Study

Graham KL, Amat M, Norian E, Li J, Weintraub J, Shaik A, Boggan JC, Davy J, Lyons A, Semour L, Rogers R, Davis RB. Differences[...]

Comparative assessment of CAC and SIS plaque burden categories via AI-guided quantitative CT analysis

Iskander B, Ichikawa K, Punnanithinont N, Kambalapalli S, Kinninger A, Krishnan S, Lakshmanan S, Roy S, Budoff MJ. Comparative assessment of CAC and SIS plaque[...]

Association of Mechanical Circulatory Support and Cardiac Catheterization Laboratory Procedural Volumes with Outcomes of Cardiogenic Shock

Tabibian K, Vadlakonda A, Coaston T, Sakowitz S, Ebrahimian S, Srivastava PK, Benharash P. Association of Mechanical Circulatory Support and Cardiac Catheterization Laboratory Procedural Volumes[...]